ARCHIVES
VOL. 3, ISSUE 1 (2018)
Brief study of regulations for preventing counterfeit drugs in USA, Europe, India and Brazil
Authors
Smruti Goswami, Darshil Shah, Dr. Dilip G Maheshwari
Abstract
Counterfeit medications are a worldwide issue with huge and wellâ€documented outcomes for worldwide well being and patient security, including drug protection and patient passing. The quintessence of fake items and the reason they are so hazardous is the total nonattendance of value control, since they are regularly indistinct from the certified item. The presence of fake medications has for quite some time been disregarded both by the pharmaceutical business and by tranquilize administrative experts. At present initiative are being taken, broadly and universally, to control counterfeit drugs. In context to battle against counterfeit medications, governments over the globe are taking steps to stringent pharmaceutical controls, making pharmaceutical serialization mandatory.
Download
Pages:206-208
How to cite this article:
Smruti Goswami, Darshil Shah, Dr. Dilip G Maheshwari "Brief study of regulations for preventing counterfeit drugs in USA, Europe, India and Brazil". International Journal of Research in Pharmacy and
Pharmaceutical Sciences, Vol 3, Issue 1, 2018, Pages 206-208
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.

